600 MADISON AVENUE, SUITE 1601, NEW YORK, NY
Market cap: $37.5M (2/09/2026)
Price: $2.27
Reports Q2 Fiscal Year 2026 Financial Results and Provides Corporate Update
$26 Million Private Placement
Annual Meeting of Stockholders - Director Elections Held on November 20, 2025
News
Reports Q1 Fiscal Year 2026 Financial Results and Provides Corporate Update
Other Events
Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
Annual Report to Security Holders
Q2
Amended Quarterly Report
Q1
FY 2025
Q3
Amended Annual Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Schedule 13G - Ownership Report